SCHEMBL25842102

SCHEMBL25842102

CCC(CC)CC(CO)NC(=O)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 3/20 0.34
CNR1 P21554 1/20 0.34
ADRA1A P35348 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ABCC3 O15438 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CNR2 P34972 1/20 0.33
MMP2 P08253 3/20 0.31
MMP9 P14780 2/20 0.31
MMP12 P39900 2/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
MMP1 P03956 1/20 0.31
MMP8 P22894 1/20 0.31
CA9 Q16790 1/20 0.31
MME P08473 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25839087 0.85 CYP3A4 (0.36) CYP3A4MAPK1LMNACNR1ADRA1A
SCHEMBL825584 0.84 TDP1 (0.44) CYP3A4MAPK1LMNACNR1ADRA1A
SCHEMBL13035554 0.82 TAS1R3 (0.40) CYP3A4MAPK1LMNACNR1CNR2
SCHEMBL14269010 0.82 TAS1R3 (0.40) CYP3A4MAPK1LMNACNR1CNR2
SCHEMBL13034816 0.82 TAS1R3 (0.40) CYP3A4MAPK1LMNACNR1CNR2
SCHEMBL7990837 0.81 CYP3A4 (0.43) CYP3A4MAPK1LMNACNR1ADRA1A
SCHEMBL8899976 0.77 MMP1 (0.48) MAPK1LMNATDP1SMN1; SMN2CNR2
SCHEMBL14268998 0.76 TAS1R3 (0.40) CYP3A4MAPK1CNR1ADRA1ATDP1
SCHEMBL12156779 0.73 DPP7 (0.41) CNR1CA1CA2
SCHEMBL30952371 0.73 USP2 (0.47) CYP3A4MAPK1LMNACNR1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515449-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2023-07-12 EP disclosed